172 related articles for article (PubMed ID: 19958395)
21. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation.
Ikutomi M; Sahara M; Nakajima T; Minami Y; Morita T; Hirata Y; Komuro I; Nakamura F; Sata M
J Mol Cell Cardiol; 2015 Sep; 86():121-35. PubMed ID: 26231083
[TBL] [Abstract][Full Text] [Related]
22. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension.
Junhui Z; Xingxiang W; Guosheng F; Yunpeng S; Furong Z; Junzhu C
Respir Med; 2008 Jul; 102(7):1073-9. PubMed ID: 18394873
[TBL] [Abstract][Full Text] [Related]
23. In vivo perfusion of human skin substitutes with microvessels formed by adult circulating endothelial progenitor cells.
Kung EF; Wang F; Schechner JS
Dermatol Surg; 2008 Feb; 34(2):137-46. PubMed ID: 18190540
[TBL] [Abstract][Full Text] [Related]
24. Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension.
Ormiston ML; Deng Y; Stewart DJ; Courtman DW
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):546-54. PubMed ID: 19995942
[TBL] [Abstract][Full Text] [Related]
25. [Magnetic resonance imaging of magnetically labeled endothelial progenitor cells homing to the injured endothelium].
Ma ZL; Teng GJ; Mai XL; Ju SH; Deng G; Sun JH; Zhang HY; Yu H; Li GZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):679-84. PubMed ID: 17553305
[TBL] [Abstract][Full Text] [Related]
26. Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.
Granton J; Langleben D; Kutryk MB; Camack N; Galipeau J; Courtman DW; Stewart DJ
Circ Res; 2015 Sep; 117(7):645-54. PubMed ID: 26195220
[TBL] [Abstract][Full Text] [Related]
27. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.
Jurasz P; Courtman D; Babaie S; Stewart DJ
Pharmacol Ther; 2010 Apr; 126(1):1-8. PubMed ID: 20117135
[TBL] [Abstract][Full Text] [Related]
28. Detection and characterization of circulating endothelial progenitor cells in normal rat blood.
Thomas RA; Pietrzak DC; Scicchitano MS; Thomas HC; McFarland DC; Frazier KS
J Pharmacol Toxicol Methods; 2009; 60(3):263-74. PubMed ID: 19577656
[TBL] [Abstract][Full Text] [Related]
29. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.
Ben-Shoshan J; George J
Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679
[TBL] [Abstract][Full Text] [Related]
30. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.
Hristov M; Weber C
J Cell Mol Med; 2004; 8(4):498-508. PubMed ID: 15601578
[TBL] [Abstract][Full Text] [Related]
31. Concise review: Circulating endothelial progenitor cells for vascular medicine.
Asahara T; Kawamoto A; Masuda H
Stem Cells; 2011 Nov; 29(11):1650-5. PubMed ID: 21948649
[TBL] [Abstract][Full Text] [Related]
32. Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases.
Brixius K; Funcke F; Graf C; Bloch W
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):705-10. PubMed ID: 17001208
[TBL] [Abstract][Full Text] [Related]
33. Sildenafil improves long-term effect of endothelial progenitor cell-based treatment for monocrotaline-induced rat pulmonary arterial hypertension.
Yen CH; Tsai TH; Leu S; Chen YL; Chang LT; Chai HT; Chung SY; Chua S; Tsai CY; Chang HW; Ko SF; Sun CK; Yip HK
Cytotherapy; 2013 Feb; 15(2):209-23. PubMed ID: 23321332
[TBL] [Abstract][Full Text] [Related]
34. Studying vascular progenitor cells in a neonatal mouse model.
Kienstra KA; Hirschi KK
Methods Mol Biol; 2012; 904():235-42. PubMed ID: 22890936
[TBL] [Abstract][Full Text] [Related]
35. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation.
Cui B; Huang L; Fang Y; Guo R; Yin Y; Zhao X
Microvasc Res; 2011 Jan; 81(1):143-50. PubMed ID: 20888843
[TBL] [Abstract][Full Text] [Related]
36. Endothelial progenitor cells are reduced in refractory hypertension.
Oliveras A; Soler MJ; Martínez-Estrada OM; Vázquez S; Marco-Feliu D; Vila JS; Vilaró S; Lloveras J
J Hum Hypertens; 2008 Mar; 22(3):183-90. PubMed ID: 17992252
[TBL] [Abstract][Full Text] [Related]
37. Endothelial progenitor cells: past, state of the art, and future.
Iwami Y; Masuda H; Asahara T
J Cell Mol Med; 2004; 8(4):488-97. PubMed ID: 15601577
[TBL] [Abstract][Full Text] [Related]
38. Endothelial progenitor cells and vascular repair.
Zhang M; Malik AB; Rehman J
Curr Opin Hematol; 2014 May; 21(3):224-8. PubMed ID: 24637956
[TBL] [Abstract][Full Text] [Related]
39. Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases.
Guerra G; Perrotta F; Testa G
Curr Pharm Biotechnol; 2018; 19(9):700-707. PubMed ID: 30332949
[TBL] [Abstract][Full Text] [Related]
40. Endothelial progenitor cells for cardiovascular regeneration.
Kawamoto A; Losordo DW
Trends Cardiovasc Med; 2008 Jan; 18(1):33-7. PubMed ID: 18206807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
